Invention Grant
US09133141B2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
有权
半胱氨酸和胱氨酸生物电解质治疗精神分裂症并减少药物渴求
- Patent Title: Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
- Patent Title (中): 半胱氨酸和胱氨酸生物电解质治疗精神分裂症并减少药物渴求
-
Application No.: US14148959Application Date: 2014-01-07
-
Publication No.: US09133141B2Publication Date: 2015-09-15
- Inventor: James M. Cook , David A. Baker , Edward Merle Johnson, II , Wenyuan Yin , Ranjit Singh Verma
- Applicant: Marquette University , UWM Research Foundation, Inc.
- Applicant Address: US WI Milwaukee US WI Milwaukee
- Assignee: Marquette University,UWM Research Foundation, Inc.
- Current Assignee: Marquette University,UWM Research Foundation, Inc.
- Current Assignee Address: US WI Milwaukee US WI Milwaukee
- Agency: Quarles & Brady LLP
- Main IPC: C07D271/06
- IPC: C07D271/06 ; C07D249/08 ; C07D413/12 ; C07K5/062 ; C07K5/103
Abstract:
The present invention provides cysteine and cystine bioisosteres for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing such bioisosteres and methods of using the bioisosteres for treatment of schizophrenia and drug addiction.
Public/Granted literature
- US20140155440A1 CYSTEINE AND CYSTINE BIOISOSTERES TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS Public/Granted day:2014-06-05
Information query
